ArticleAmerican journal of cancer research2021

Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.

Alfredo Minguela et al.PubMed ↗Full text ↗

No numbers read from the abstract.